Sign in
CDIO Stock Price, Chart, Stats & News
Cardio Diagnostics Holdings, Inc.
Save
4.56M
Market cap
–
Current P/E
–
Forward P/E
CDIO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -2180.21% |
Operating margin | -43737.46% |
Pretax margin | -43832.49% |
Net margin | -43832.49% |
Effective tax rate | – |
ROA | -83.67% |
ROE | -71.75% |
D/E | 0.10x |
Interest coverage ratio | -438.08x |
CDIO valuation
P/E | – |
P/S | 245.63x |
P/B | 0.51x |
P/CF | -0.63x |
P/FCF | -0.61x |
P/OCF | -0.63x |
PEG | 0.02x |
EV multiple | -1.32x |
About
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Similar securities
Based on sector and market capitalization
Report issue